Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
NCT ID: NCT00704132
Description: The analyses for all safety outcomes used the All Patients as Treated (APaT) approach. The APaT population used all randomized participants who received at least 1 dose of study therapy.
Frequency Threshold: 5
Time Frame: None
Study: NCT00704132
Study Brief: Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sitagliptin Participants were administered sitagliptin 100 mg tablet once daily before the morning meal for six weeks. None None 1 26 0 26 View
Placebo Participants were administered sitagliptin matching placebo tablet once daily before the morning meal for six weeks. None None 0 24 0 24 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Vertigo positional SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA 12.2 View
Other Events(If Any):